548 related articles for article (PubMed ID: 33603158)
1. Genetic engineering of T cells for immunotherapy.
Ellis GI; Sheppard NC; Riley JL
Nat Rev Genet; 2021 Jul; 22(7):427-447. PubMed ID: 33603158
[TBL] [Abstract][Full Text] [Related]
2. Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy.
Ren YB; Sun SJ; Han SY
Curr Pharm Des; 2018; 24(1):78-83. PubMed ID: 29283058
[TBL] [Abstract][Full Text] [Related]
3. On the mark: genetically engineered immunotherapies for autoimmunity.
Ellebrecht CT; Lundgren DK; Payne AS
Curr Opin Immunol; 2019 Dec; 61():69-73. PubMed ID: 31563849
[TBL] [Abstract][Full Text] [Related]
4. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
5. Applications of molecular engineering in T-cell-based immunotherapies.
McBride DA; Kerr MD; Wai SL; Shah NJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Sep; 11(5):e1557. PubMed ID: 30972976
[TBL] [Abstract][Full Text] [Related]
6. Genetic engineering of T cells with chimeric antigen receptors for hematological malignancy immunotherapy.
Ti D; Niu Y; Wu Z; Fu X; Han W
Sci China Life Sci; 2018 Nov; 61(11):1320-1332. PubMed ID: 30414005
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell Carcinoma.
Qureshi HA; Lee SM
Curr Treat Options Oncol; 2019 Mar; 20(4):31. PubMed ID: 30874960
[TBL] [Abstract][Full Text] [Related]
8. Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies.
Abbott RC; Cross RS; Jenkins MR
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947597
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
Tomuleasa C; Fuji S; Berce C; Onaciu A; Chira S; Petrushev B; Micu WT; Moisoiu V; Osan C; Constantinescu C; Pasca S; Jurj A; Pop L; Berindan-Neagoe I; Dima D; Kitano S
Front Immunol; 2018; 9():239. PubMed ID: 29515572
[TBL] [Abstract][Full Text] [Related]
10. Principles of adoptive T cell therapy in cancer.
Met Ö; Jensen KM; Chamberlain CA; Donia M; Svane IM
Semin Immunopathol; 2019 Jan; 41(1):49-58. PubMed ID: 30187086
[TBL] [Abstract][Full Text] [Related]
11. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
Ikeda H
Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
[TBL] [Abstract][Full Text] [Related]
12. Current Status of Gene Engineering Cell Therapeutics.
Saudemont A; Jespers L; Clay T
Front Immunol; 2018; 9():153. PubMed ID: 29459866
[No Abstract] [Full Text] [Related]
13. The making and function of CAR cells.
Zabel M; Tauber PA; Pickl WF
Immunol Lett; 2019 Aug; 212():53-69. PubMed ID: 31181279
[TBL] [Abstract][Full Text] [Related]
14. Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.
Srivastava S; Riddell SR
J Immunol; 2018 Jan; 200(2):459-468. PubMed ID: 29311388
[TBL] [Abstract][Full Text] [Related]
15. Engineering Platforms for T Cell Modulation.
Hickey JW; Kosmides AK; Schneck JP
Int Rev Cell Mol Biol; 2018; 341():277-362. PubMed ID: 30262034
[TBL] [Abstract][Full Text] [Related]
16. Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy.
Mirzaei HR; Pourghadamyari H; Rahmati M; Mohammadi A; Nahand JS; Rezaei A; Mirzaei H; Hadjati J
Cancer Lett; 2018 Jun; 423():95-104. PubMed ID: 29544719
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer.
Li F; Zhang T; Cao L; Zhang Y
Curr Stem Cell Res Ther; 2018; 13(5):327-335. PubMed ID: 29676233
[TBL] [Abstract][Full Text] [Related]
18. Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns.
Resetca D; Neschadim A; Medin JA
J Immunother; 2016 Sep; 39(7):249-59. PubMed ID: 27488725
[TBL] [Abstract][Full Text] [Related]
19. Generation of Redirected Engineered Human Chimeric Antigen Receptor (CAR) T Cells.
Bunse M; Höpken UE
Methods Mol Biol; 2022; 2521():67-83. PubMed ID: 35732993
[TBL] [Abstract][Full Text] [Related]
20. Driving gene-engineered T cell immunotherapy of cancer.
Johnson LA; June CH
Cell Res; 2017 Jan; 27(1):38-58. PubMed ID: 28025979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
